HF
EVGN icon

HRT Financial’s Evogene EVGN Stock Holding History

HRT Financial’s Portfolio EVGN Stock Details EVGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-1,521
Closed -$8K – 2518
2023
Q3 		$8K Buy
+1,521
New +$13.3K ﹤0.01% 2140
2022
Q1 		– Sell
-1,345
Closed -$22K – 3298
2021
Q4 		$22K Buy
+1,345
New +$30.5K ﹤0.01% 2938
2021
Q2 		– Sell
-1,504
Closed -$75K – 3022
2021
Q1 		$75K Buy
+1,504
New +$93.1K ﹤0.01% 2492

Other funds holding EVGN

SCM
Silverarc Capital Management Boston, Massachusetts $980M AUM 470.8% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Walleye Capital
Walleye Capital New York $24B AUM 37.67% 1-Year Est. Return
CCM
Connective Capital Management Palo Alto, California $121M AUM 39.82% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

HRT Financial's EVGN Position: Q4 2023 in Review

HRT Financial sold out of Evogene (EVGN) in Q4 2023, closing a stake of 1,521 shares — an estimated $8K sold.

HRT Financial first reported a position in EVGN in Q1 2021 and held it in 3 quarters. The position peaked at $75K in Q1 2021. 33 funds tracked by Wall St. Rank hold EVGN as of Q4 2023.

  • HRT Financial reported no remaining Evogene position as of Q4 2023 after selling out during the quarter.
  • HRT Financial sold 1,521 Evogene shares in Q4 2023, an estimated $8K.
  • HRT Financial first reported a position in Evogene in Q1 2021 and held it in 3 quarters.
  • HRT Financial's Evogene position peaked at $75K in Q1 2021.
  • 33 funds tracked by Wall St. Rank held Evogene as of Q4 2023.

Based on HRT Financial's 13F filing for Q4 2023, filed 9 Feb 2024.